PPARA and obesity due to melanocortin 4 receptor deficiency: In addition, the transcription factor, PPAR-α has been suggested to be a therapeutic target for obesity [46] as targeting of this gene can improve serum lipid profiles, lipoprotein metabolism, and fatty acid β-oxidation [47].